Reproductive and Lifestyle Factors and Circulating sRANKL and OPG Concentrations in Women: Results from the EPIC Cohort.


Journal

Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology
ISSN: 1538-7755
Titre abrégé: Cancer Epidemiol Biomarkers Prev
Pays: United States
ID NLM: 9200608

Informations de publication

Date de publication:
10 2019
Historique:
received: 08 03 2019
revised: 06 05 2019
accepted: 03 07 2019
pubmed: 12 7 2019
medline: 25 9 2020
entrez: 12 7 2019
Statut: ppublish

Résumé

Except for a documented increase in osteoprotegerin (OPG) concentrations with older age, data on determinants of soluble Receptor Activator of Nuclear Factor κB (sRANKL) and OPG concentrations in women are limited. We evaluated reproductive and lifestyle factors as potential sources of variation in circulating sRANKL and OPG concentrations in pre- and postmenopausal women. This study includes 2,016 controls [ Older age at blood collection was associated with lower sRANKL concentrations in postmenopausal women ( Circulating sRANKL and OPG concentrations are minimally impacted by hormone-related factors in pre- and postmenopausal women. This study suggests circulating concentrations of sRANKL and OPG are unlikely to be strongly modified by hormone-related reproductive and lifestyle factors.

Sections du résumé

BACKGROUND
Except for a documented increase in osteoprotegerin (OPG) concentrations with older age, data on determinants of soluble Receptor Activator of Nuclear Factor κB (sRANKL) and OPG concentrations in women are limited. We evaluated reproductive and lifestyle factors as potential sources of variation in circulating sRANKL and OPG concentrations in pre- and postmenopausal women.
METHODS
This study includes 2,016 controls [
RESULTS
Older age at blood collection was associated with lower sRANKL concentrations in postmenopausal women (
CONCLUSIONS
Circulating sRANKL and OPG concentrations are minimally impacted by hormone-related factors in pre- and postmenopausal women.
IMPACT
This study suggests circulating concentrations of sRANKL and OPG are unlikely to be strongly modified by hormone-related reproductive and lifestyle factors.

Identifiants

pubmed: 31292137
pii: 1055-9965.EPI-19-0241
doi: 10.1158/1055-9965.EPI-19-0241
doi:

Substances chimiques

Biomarkers 0
Osteoprotegerin 0
RANK Ligand 0
TNFRSF11B protein, human 0
TNFSF11 protein, human 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1746-1754

Subventions

Organisme : Cancer Research UK
ID : C8221/A19170
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/N003284/1
Pays : United Kingdom
Organisme : Medical Research Council
ID : G1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : 1000143
Pays : United Kingdom
Organisme : Medical Research Council
ID : G0401527
Pays : United Kingdom
Organisme : Medical Research Council
ID : MR/M012190/1
Pays : United Kingdom
Organisme : Cancer Research UK
ID : 14136
Pays : United Kingdom
Organisme : Cancer Research UK
ID : C570/A16491
Pays : United Kingdom

Informations de copyright

©2019 American Association for Cancer Research.

Auteurs

Danja Sarink (D)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jiaxi Yang (J)

Department of Epidemiology, Harvard School of Public Health, Boston, Massachusetts.

Theron Johnson (T)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Jenny Chang-Claude (J)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
University Cancer Center Hamburg, Cancer Epidemiology Group, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.

Kim Overvad (K)

Department of Public Health, Aarhus University, Aarhus, Denmark.

Anja Olsen (A)

Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.

Anne Tjønneland (A)

Diet, Genes and Environment, Danish Cancer Society Research Center, Copenhagen, Denmark.
Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.

Agnès Fournier (A)

CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Francesca Romana Mancini (FR)

CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Marina Kvaskoff (M)

CESP, Fac. de médecine - Univ. Paris-Sud, Fac. de médecine - UVSQ, INSERM, Université Paris-Saclay, Villejuif, France.
Gustave Roussy, Villejuif, France.

Heiner Boeing (H)

Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Nuthetal, Germany.

Antonia Trichopoulou (A)

Hellenic Health Foundation, Athens, Greece.

Anna Karakatsani (A)

Hellenic Health Foundation, Athens, Greece.
2nd Pulmonary Medicine Department, School of Medicine, National and Kapodistrian University of Athens, "ATTIKON" University Hospital, Haidari, Greece.

Elissavet Valanou (E)

Hellenic Health Foundation, Athens, Greece.

Claudia Agnoli (C)

Epidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Carlotta Sacerdote (C)

Unit of Cancer Epidemiology, Città della Salute e della Scienza University-Hospital and Center for Cancer Prevention (CPO), Turin, Italy.

Giovanna Masala (G)

Cancer Risk Factors and Life-Style Epidemiology Unit, Institute for Cancer Research, Prevention and Clinical Network - ISPRO, Florence, Italy.

Amalia Mattiello (A)

Dipartimento di Medicina Clinica e Chirurgia, Federico II University, Naples, Italy.

Rosario Tumino (R)

Cancer Registry and Histopathology Department, "Civic M.P.Arezzo," Hospital, Azienda Sanitaria Provinciale, Ragusa, Italy.

Carla H Van Gils (CH)

Department of Epidemiology, Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, the Netherlands.

Guri Skeie (G)

Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.
Nutritional Epidemiology Group, School of Food Science and Nutrition, University of Leeds, Leeds, United Kingdom.

Inger Torhild Gram (IT)

Department of Community Medicine, UiT the Arctic University of Norway, Tromsø, Norway.

Elisabete Weiderpass (E)

International Agency for Research on Cancer, Lyon, France.

Leila Lujan-Barroso (L)

Unit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology (ICO-IDIBELL), Barcelona, Spain.

Dafina Petrova (D)

Escuela Andaluza de Salud Pública, Instituto de Investigación Biosanitaria ibs. Granada, Universidad de Granada, Granada, Spain.
CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.

Carmen Santiuste (C)

CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Department of Epidemiology, Murcia Regional Health Authority, IMIB-Arrixaca, Murcia, Spain.

J Ramón Quirós (JR)

Public Health Directorate, Asturias, Spain.

Aurelio Barricarte (A)

CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Navarra Public Health Institute, Pamplona, Spain.
Navarra Institute for Health Research (IdiSNA), Pamplona, Spain.

Pilar Amiano (P)

CIBER de Epidemiología y Salud Pública (CIBERESP), Madrid, Spain.
Public Health Division of Gipuzkoa, BioDonostia Research Institute, San Sebastian, Spain.

Ruth C Travis (RC)

Cancer Epidemiology Unit, Nuffield Department of Population Health, University of Oxford, Oxford, United Kingdom.

Marc Gunter (M)

International Agency for Research on Cancer, Lyon, France.

Laure Dossus (L)

International Agency for Research on Cancer, Lyon, France.

Sofia Christakoudi (S)

Department of Epidemiology and Biostatistics, Imperial College London, London, United Kingdom.
MRC Centre for Transplantation, King's College London, London, United Kingdom.

Rudolf Kaaks (R)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.

Renée Turzanski Fortner (RT)

Division of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany. r.fortner@dkfz.de.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH